Christina M. Ackermann

Executive Vice President, General Counsel at Valeant Pharmaceuticals International Corp.

Christina M. Ackermann

Christina M. Ackermann

Executive Vice President, General Counsel at Valeant Pharmaceuticals International Corp.

Overview
Career Highlights

Bausch Health Cos., Inc.
Valeant Pharmaceuticals International Corp.
Alcon, Inc.

RelSci Relationships

1904

Number of Boards

1

Birthday

1965

Age

54

Contact Data
Trying to get in touch with Christina M. Ackermann? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Christina M. Ackermann likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman of the Board & Chief Executive Officer at Bausch Health Cos., Inc.

Relationship likelihood: Strong

Secretary & Director at Valeant Pharmaceuticals Australasia Pty Ltd.

Relationship likelihood: Strong

Former Chief Executive Officer at Bausch Health Cos., Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Synergetics USA, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Solta Medical, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Executive Vice President at Aton Pharma, Inc.

Relationship likelihood: Strong

Director, Executive Vice President & General Counsel at Valeant Canada Ltd.

Relationship likelihood: Strong

Executive Partner, Chief Operating Officer at Flagship Pioneering

Relationship likelihood: Strong

Executive Vice President & Chief Financial Officer at Valeant Pharmaceuticals International Corp.

Relationship likelihood: Strong

Former Director at Synergetics USA, Inc.

Relationship likelihood: Strong

Paths to Christina M. Ackermann
Potential Connections via
Relationship Science
You
Christina M. Ackermann
Executive Vice President, General Counsel at Valeant Pharmaceuticals International Corp.
Education
Bachelor of Laws

Queen's University at Kingston (commonly shortened to Queen's University or Queen's) is a public research university located in Kingston, Ontario, Canada. Founded on 16 October 1841, the university predated the founding of Canada by 26 years. Queen's holds more than 1,400 hectares (3,500 acres) of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England. Queen's is organized into ten undergraduate, graduate and professional faculties and schools. The Church of Scotland established Queen's College in 1841 with a royal charter from Queen Victoria. The first classes, intended to prepare students for the ministry, were held 7 March 1842 with 13 students and two professors. Queen's was the first university west of the maritime provinces to admit women, and to form a student government. In 1883, a women's college for medical education affiliated with Queen's University. In 1888, Queen's University began offering extension courses, becoming the first Canadian university to do so. In 1912, Queen's secularized and changed to its present legal name.

Post Graduate Diploma in EC Competition Law

The University of London is a collegiate research university located in London, England, consisting of 18 constituent colleges, 10 research institutes and a number of central bodies. The nine largest institutions of the federal university, usually termed the colleges, are Birkbeck, Goldsmiths, King's College London, the London Business School, Queen Mary, Royal Holloway, SOAS, LSE and UCL. Formerly a constituent college, Imperial College London left the University of London in 2007.

Career History
Executive Vice President & General Counsel
2016 - Current

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment refers to the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Executive Vice President, General Counsel
Current

Valeant Pharmaceuticals International Corp. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.

Secretary & Director
Current

Synergetics USA, Inc. designs, manufactures and supplies precision surgical devices. It also designs and manufactures disposable and non-disposable supplies and accessories. The firm's product lines focus upon precision engineered, disposable and reusable devices, surgical equipment, procedural kits and the delivery of various energy modalities for the performance of surgery, including laser energy, ultrasonic energy, radio frequency energy for electrosurgery and lesion generation and visible light energy for illumination. The company was founded on June 2, 2005 and is headquartered in O'Fallon, MO.

Boards & Committees
Secretary & Director
Current

Synergetics USA, Inc. designs, manufactures and supplies precision surgical devices. It also designs and manufactures disposable and non-disposable supplies and accessories. The firm's product lines focus upon precision engineered, disposable and reusable devices, surgical equipment, procedural kits and the delivery of various energy modalities for the performance of surgery, including laser energy, ultrasonic energy, radio frequency energy for electrosurgery and lesion generation and visible light energy for illumination. The company was founded on June 2, 2005 and is headquartered in O'Fallon, MO.

Transactions
Details Hidden

The Carlyle Group LP (Corporate Private Equity), Pacific Equity Partners Pty Ltd., Inova Pharmaceuticals Australia Pty. Ltd. /Pvt. Group purchase iNova Pharmaceuticals (Australia) Pty Ltd. from Bausch Health Cos., Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christina M. Ackermann. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christina M. Ackermann's profile does not indicate a business or promotional relationship of any kind between RelSci and Christina M. Ackermann.